BVS

Bioventus Inc. (BVS) Stock Analysis: Unlocking a 66.89% Potential Upside in the Medical Device Sector

Bioventus Inc. (NASDAQ: BVS) is capturing the attention of investors in the healthcare sector with its promising potential upside and a strong portfolio of innovative medical devices targeting pain relief..

Bioventus Inc. (BVS) Stock Analysis: Exploring a Potential 75% Upside Opportunity

Bioventus Inc. (NASDAQ: BVS), a prominent player in the healthcare sector, specializes in medical devices aimed at alleviating pain and enhancing musculoskeletal therapies in the U.S. and beyond. With a..

Bioventus Inc. (BVS): Stock Analysis and Investor Outlook with a Promising 85% Upside Potential

Bioventus Inc. (NASDAQ: BVS), headquartered in Durham, North Carolina, is making waves in the healthcare sector with its innovative medical devices aimed at alleviating pain and enhancing musculoskeletal therapies. With..

Bioventus Inc. (BVS) Stock Analysis: Exploring a Potential 91.81% Upside in the Medical Device Sector

Bioventus Inc. (NASDAQ: BVS), a notable player in the healthcare sector, specializes in innovative medical devices aimed at alleviating pain and addressing musculoskeletal therapies. With a current market capitalization of..

Bioventus Inc. (BVS) Stock Analysis: Exploring an 83% Potential Upside

Bioventus Inc. (NASDAQ: BVS), a prominent player in the healthcare sector specializing in medical devices, is drawing attention from investors looking for substantial growth opportunities. With a market capitalization of..

Bioventus Inc. (BVS) Stock Analysis: Exploring a Potential 89% Upside in the Medical Devices Sector

Bioventus Inc. (NASDAQ: BVS), a prominent name in the healthcare sector, specializes in medical devices aimed at pain relief and musculoskeletal therapies. Headquartered in Durham, North Carolina, Bioventus has carved..

Bioventus Inc. (BVS) Stock Analysis: Exploring an 88% Potential Upside in the Healthcare Sector

Bioventus Inc. (NASDAQ: BVS) is making waves in the healthcare sector with an enticing potential upside of 88%, as noted by recent analyst ratings. Specializing in medical devices, this Durham,..

Bioventus Inc. (BVS) Stock Analysis: Exploring an 89% Potential Upside in the Medical Device Sector

Bioventus Inc. (NASDAQ: BVS) sits at a pivotal intersection of the healthcare and medical device sectors, offering a diverse array of products aimed at alleviating pain and enhancing musculoskeletal health...

Bovis Homes Group PLC Completes Acquisition of the Linden Homes and Partnerships & Regeneration businesses

Bovis Homes Group PLC (LON: BVS) has announced that it has completed the acquisition of Galliford Try plc’s (LON: GFRD) Linden Homes and Partnerships & Regeneration businesses. Greg Fitzgerald, CEO..

Bovis Homes Group PLC acquisition of Galliford Try plc’s Linden Homes and Partnerships & Regeneration businesses

Bovis Homes Group PLC (LON: BVS) has announced that it has agreed to acquire Galliford Try plc‘s Linden Homes and Partnerships & Regeneration businesses for consideration of £1.075 billion[1]. The..

Bovis Homes Group plc Strong first half performance

Bovis Homes Group plc (LON:BVS) has issued a trading update for the six month period ended 30 June 2019 ahead of reporting its half year results on 10 September 2019...

Bovis Homes Group Statement regarding Galliford Try

In view of the recent press speculation and the announcement by Galliford Try plc , Bovis Homes Group (LON:BVS) confirmed that following an initial proposal, some preliminary discussions and the..

Bovis Homes Group PLC Strong period of trading & a step up in sales rate

Bovis Homes Group PLC (LON:BVS) is holding its Annual General Meeting at 12:00pm today in Tunbridge Wells. This statement comments on the Group’s current trading and outlook for the financial..

Bovis Homes Group PLC Completion of Stanton Cross Joint Venture

Bovis Homes Group PLC (LON:BVS) today announced the completion of a 50:50 joint venture with Riverside, one of the UK’s leading registered providers of social housing, for the development of..

Bovis Homes Group PLC Excellent operational progress, 47% increase in profits

Bovis Homes Group PLC (LLON:BVS) is today issuing its full year results for the 12 months ended 31 December 2018. Highlights – Significant operational improvements deliver step change in business..

Bovis Homes Group PLC Significant improvement in operational performance across all areas

Bovis Homes Group PLC (LON:BVS) today issued a trading update for the year ended 31 December 2018 ahead of the publication of its annual results on 28 February 2019. Highlights..

Bovis Homes Group PLC In a strong sales position

Bovis Homes Group PLC (LON:BVS) today issued a trading update in respect of the period from 1 July to 11 November 2018. Greg Fitzgerald, Group CEO said “The Group’s improved..

Bovis Homes Group PLC appoint Katherine Innes Ker as non-executive director

The Board of Bovis Homes Group PLC (LON:BVS) today announced that Katherine Innes Ker has been appointed a non-executive director of the Company with effect from today, 9 October 2018...

Bovis Home Group excellent progress made across all business areas

Bovis Home Group (LON:BVS), today announced half year results for the six months ended 30 June 2018. H1 Highlights · Strong H1 performance with a 41% increase in profit before..

Hardman & Co Q&A with Research Analyst Tony Williams

Hardman and Co Research Analyst Head of Research Tony Williams caught up with DirectorsTalk for an exclusive interview to discuss the housebuilding sector for 2016/2017: what companies did and didn’t..

Search

Funds

BVS

Search

Funds

BVS

FTSE 100

Funds